You are here

  • Home
  • Archive
  • Volume 73, Issue 11
  • Non-viral opportunistic infections in new users of tumour necrosis factor inhibitor therapy: results of the SAfety Assessment of Biologic ThERapy (SABER) Study

Citation Tools

Article menu
Download PDFPDF
Clinical and epidemiological research
Extended report
Non-viral opportunistic infections in new users of tumour necrosis factor inhibitor therapy: results of the SAfety Assessment of Biologic ThERapy (SABER) Study

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Baddley JW, Winthrop KL, Chen L, et al
Non-viral opportunistic infections in new users of tumour necrosis factor inhibitor therapy: results of the SAfety Assessment of Biologic ThERapy (SABER) Study
Annals of the Rheumatic Diseases 2014;73:1942-1948.